Date published: 2026-1-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

mannosidase Inhibitors

Santa Cruz Biotechnology now offers a broad range of mannosidase inhibitors for use in various applications. Mannosidase inhibitors are crucial in scientific research for studying the role of glycoprotein processing in cellular functions. These inhibitors target mannosidases, enzymes responsible for the cleavage of mannose residues from glycoproteins and glycolipids, and are used to explore the effects of inhibiting this step on protein folding, quality control, and trafficking within the endoplasmic reticulum and Golgi apparatus. By utilizing mannosidase inhibitors, researchers can investigate the mechanisms underlying disorders related to glycosylation and the accumulation of misfolded proteins. These compounds are also employed in studies to understand how glycoprotein processing affects cell signaling, adhesion, and immune response. Additionally, mannosidase inhibitors are valuable tools in the development of new methodologies for the synthesis and characterization of complex glycans. They enable the exploration of potential experimental targets for various conditions by modulating glycoprotein metabolism and influencing cellular homeostasis. Overall, mannosidase inhibitors are indispensable in advancing our understanding of glycoprotein biology and their impact on cellular processes. View detailed information on our available mannosidase inhibitors by clicking on the product name.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(1S,2S,3R)-1,2,3-Trihydroxy-4-cyclopropene 2,3-Cyclohexyl Ketal

134677-23-9sc-391231
25 mg
$360.00
(0)

(1S,2S,3R)-1,2,3-Trihydroxy-4-cyclopropene 2,3-Cyclohexyl Ketal exhibits distinctive properties as a mannosidase, characterized by its ability to form stable enzyme-substrate complexes. Its unique stereochemistry enhances binding affinity, facilitating specific molecular interactions that modulate reaction kinetics. This compound influences glycan biosynthesis pathways, potentially altering the structural diversity of glycoproteins and impacting cellular communication mechanisms.

N-Butyldeoxymannojirimycin HCl

155501-85-2sc-286394
sc-286394A
1 mg
2 mg
$170.00
$300.00
(0)

N-Butyldeoxymannojirimycin HCl functions as a mannosidase inhibitor, showcasing a remarkable ability to disrupt glycosidic bond hydrolysis. Its structural conformation allows for selective binding to the active site of mannosidases, effectively altering enzyme kinetics and substrate specificity. This compound's interactions can lead to significant changes in glycan processing, influencing the overall dynamics of glycoprotein maturation and cellular signaling pathways.